Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-019673

Options or other derivatives

  • Chief Scientific Officer acquired 139,273 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Reich Kristian Chief Scientific Officer 2025-02-27 Grant or award · Stock Option (Right to Buy) +139,273 139,273 D: show line 1 in the form
Loading xslF345X05/ownership.xml…